Leadership Team

Senior Management Team

GCAT's team is comprised of international and bilingual executives with
extensive experience in finance, business development, global marketing,
preclinical and clinical trials, and regulatory approval in both the US and
China.

C. Mark Tang, Ph.D., MBA, Chairman

Melinda Mingus, MD, MBA, Director, Medical Affairs

Sam Milstein, Ph.D., Chief Scientific Officer

Lewis Cahill, MBA, Financial Controller

Board of Directors and Advisers

GCAT directors and advisers are internationally recognized leaders in the pharmaceutical and finance industries.

Dr. C Mark Tang Chairman and Director (formerly with Morgan Stanley and PaineWebber/UBS)

Dr. Jordan Schreiber, Director, (formerly with Merrill Lynch and Blackrock)

Mr. Frank Stonebanks, MBA, Business Development Adviser (VP & Chief Commercial Officer at Ontario Institute for Cancer Research, formerly with Johnson & Johnson and IBM)

Dr. Christine Fischette, Adviser, (former head of business development, Novartis)